🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
41.37
-2.28 (-5.22%)
At close: Nov 20, 2026, 4:00 PM EST
41.40
+0.03 (0.07%)
After-hours: Nov 20, 2026, 7:30 PM EST

Arrowhead Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Net Income
-724.21-1.63-599.49-205.28-176.06
Depreciation & Amortization
26.6223.9318.612.4910.42
Other Amortization
2.2----
Loss (Gain) From Sale of Assets
-19----
Loss (Gain) From Sale of Investments
-4.76-5.79-3.16-4.43
Loss (Gain) on Equity Investments
3.88----
Stock-Based Compensation
68.1563.3773.9778.13120.89
Other Operating Activities
314.27117.9122.1512.312.48
Change in Accounts Receivable
-3.29-56.97-1.418.85
Change in Inventory
-9.08----
Change in Accounts Payable
12.486.29-5.5433-6.59
Change in Unearned Revenue
110.592.4-0.87-129.18-112.5
Change in Other Net Operating Assets
-49.8130.0531.4943.2311.95
Operating Cash Flow
-271.95179.55-462.85-153.89-136.13
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Capital Expenditures
-12-22.67-141.47-176.74-52.78
Sale (Purchase) of Intangibles
-215----
Investment in Securities
-443.49-106.63-278.680.5847.36
Investing Cash Flow
-670.48-129.29-420.07-96.16-5.42

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Short-Term Debt Issued
-10.26---
Long-Term Debt Issued
700-392--
Total Debt Issued
70010.26392--
Short-Term Debt Repaid
-3.47----
Long-Term Debt Repaid
-118.01-201.63---
Total Debt Repaid
-121.48-201.63---
Net Debt Issued (Repaid)
578.52-191.37392--
Issuance of Common Stock
220.84245.37452.43.055.19
Other Financing Activities
-22.552026.1225060
Financing Cash Flow
776.8274.01870.52253.0565.19

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Foreign Exchange Rate Adjustments
1.8-0.44.2-0.12-0.07
Net Cash Flow
-163.81123.86-8.212.89-76.43

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Free Cash Flow
-283.94156.89-604.32-330.63-188.91
Free Cash Flow Growth
-----
Free Cash Flow Margin
-62.98%18.92%-17018.31%-137.34%-77.67%
Free Cash Flow Per Share
-2.001.17-5.04-3.10-1.79
Levered Free Cash Flow
-587106.45-440.13-251.42-60.64
Unlevered Free Cash Flow
-530.63162.3-419.91-239.96-60.64

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Cash Interest Paid
-0.02---
Cash Income Tax Paid
-21.58-0.81-3.74-0
Change in Working Capital
60.9-18.2425.09-51.55-98.29
SEC Filings: 10-K · 10-Q